advertisements
December 29, 2005 - Even when they have equal access to specialized care, blacks with potentially curable lung cancer are about half as likely as whites to undergo surgery that could save their lives, according to a study by Dana-Farber Cancer Institute researchers.
These findings point to a subtle and complex "communications problem" underlying the inequality, said Christopher Lathan, MD, of Dana-Farber and lead author of the report that is published online by the Journal of Clinical Oncology and will be in the journal's Jan. 20 print issue.
"Something's not happening. There was no specific reason that could be found, but there needs to be more attention paid to the doctor-patient interaction."
Designed to identify the causes of racial discrepancies in lung cancer treatment in the United States, the research ruled out unequal access to medical care as the sole explanation. It did show that blacks were somewhat less likely to be offered lung cancer surgery, and were slightly more likely to refuse it than were whites. Overall, the study found that blacks who had equal access to care were 45 percent less likely than whites to have lung cancer surgery.
The generally poorer health of blacks and other racial minorities is often blamed on social and financial obstacles to obtaining medical care. The new study, however, documents that the lower rate of surgery for black lung cancer patients "is not just about access to care or not being physically able to undergo treatment," said Craig Earle, MD, of Dana-Farber and the paper's senior author. "There still seems to be a racial disparity."
According to the American Cancer Society, lung cancer is the leading cause of cancer deaths among black Americans, and blacks have the highest lung cancer mortality rate in the United States. It is estimated that 15,500 blacks will die from lung cancer in the United States in 2005 (accounting for nearly a quarter of all cancer deaths), and that more than 19,000 will be diagnosed with the disease, which is approximately 14 percent of all new cancer cases among blacks.
Yet, blacks have been previously found less likely to get surgical treatment. Someone who is diagnosed before the cancer has spread very far - Stage I or II - has up to a 50 percent chance of being alive at five years if surgery is performed. Untreated, the disease is almost always fatal.
The researchers, who also included Bridget Neville, MPH, of Dana-Farber, analyzed cancer registry records and insurance claims of 21,219 Medicare- eligible patients diagnosed with non-metastatic lung cancer between 1991 and 2001. With Medicare, inequalities due to insurance coverage were eliminated.
Of these patients, 14,224 had undergone invasive procedures to "stage" the disease by its extent, which is a guide to treatment decisions.
The procedures included bronchoscopy, the insertion of a viewing tube into the lungs, and mediastinoscopy and thoracoscopy, where surgeons make incisions in the chest wall under general anesthesia, through which viewing scopes are placed.
Blacks were 25 percent less likely than whites to have staging examinations.
But even after being referred for and undergoing staging, only 36 percent of blacks - but 50 percent of whites - were among the 6,972 who went on to receive surgical treatment. The difference in surgery rates was 45 percent.
"We thought that if all the patients had been staged - which suggests that they had access to the appropriate specialists and implies some level of trust in the medical system - that they would have the same rate of surgery," said Lathan. "We were quite surprised to find this was not the case."
The study did not address cultural factors, but Lathan said blacks might be mistrustful of the medical system and less aware of the potential benefits of the invasive surgery. Lathan, who is black and treats lung cancer patients, added that physicians may be less inclined to try and persuade reluctant black patients to strongly consider the surgery, particularly if a patient lacks good social support during recovery.
While urging further study, Lathan advised all patients to "make sure they're getting all the resources they need, even if it means challenging their physicians a little bit." For physicians, he added, "it's really important that we spend as much time thinking about how we communicate with our patients as we do about how to treat them."
The study was funded by Dana-Farber and by a National Institutes of Health training grant.
Dana-Farber Cancer Institute (www.dana-farber.org) is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), designated a comprehensive cancer center by the National Cancer Institute.
Related stories
Vitamin D Needed to Cut Cancer Risk Dec 2005 "Residents of the northeastern United States, and individuals with higher skin pigmentation were at an increased risk of vitamin D deficiency... "
Treatment Gap - Black men less likely to be treated for aggressive prostate cancer April 2, 2004. Black men with the most aggressive form of prostate cancer are less likely than white men to receive surgery or radiation therapy, according to University of Michigan.
Smoking linked to more than half of cancer deaths in black men April 2004
© 2003 Online Journal of Issues in Nursing
January 31, 2003 DISPARITIES IN HEALTH AND HEALTH CARE: FOCUSING EFFORTS TO ELIMINATE UNEQUAL BURDENSLinks and resources
Intercultural Cancer Council: African Americans and Cancer
http://iccnetwork.org/cancerfacts/cfs1.htmBlackhealthcare.com
http://www.blackhealthcare.com/Atlanta Project Targets Black Health
by Joshua Levs. NPR radio series - listen on line.Medline Plus African American Health
Sisters Network, Inc. - A National African-American Breast Cancer Survivorship Organization
http://www.sistersnetworkinc.org/default.asp
This page edited by J. Strax, last updated December 29, 2005.
Information on this web site is not intended as medical advice nor to be taken as such. Consult qualified physicians specializing in the treatment of prostate cancer. Neither the editors nor the publisher accepts any responsibility for the accuracy of the information or consequences from the use or misuse of the information contained on this web site.
About Us | Site Archive | Content Policy/Disclaimer | Privacy Policy
Here and Now: Inspiring Stories of Cancer Survivors (Paperback) by Elena Dorfman, Heidi Schultz Adams List : $21.95 Price: $14.93
advertisements
Cáncer de la próstata: respuestas a las preguntas más frecuentes by Sheldon Marks ..."Para comprender la enfermedad de la prostata y sus efectos, es preciso tener una idea general de las anatomias pelvica y genitourinaria normales..." Price $20
All-Pro Linebacker Robin Cole Read his story
Coping With Side effects of Taxotere chemo Dec 2005
Zometa® Reduces Bone Loss From Hormonal Blockade in Prostate Cancer Patients. Dec 5, 2005
We subscribe to the HONcode principles.
Verify here.